Myomo, Inc.
MYO
AMEX·Healthcare·Medical - Devices·Mkt cap $55.6M
$1.44
▲ +2.86%
P/E
-4.23
Mkt Cap
$55.6M
52-Wk Range
$0.61–$1.89
52-Week Range
$0.61 - $1.89
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 45.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary myoelectric control technology enabling patient-directed limb movement
- FDA-cleared medical device with clinical evidence supporting functional improvement
- Established relationships with VA healthcare system and rehabilitation providers
- Wearable robotics expertise and patent portfolio in neuromuscular rehabilitation
- Unique positioning in underserved market for upper limb paralysis solutions
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Expanding VA adoption and military veteran patient population
Value
Deep value opportunity - significant discount to sector peers
Momentum
Strong
+12.5% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying MYO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
AUG 5, 2026
Reported EPS of -$0.07 vs -$0.10 consensus (+28.6% surprise). Revenue of $11.7M vs $10.4M expected (+13.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+28.6%
Revenue trend · last 8Q
—
+154%
+162%
+28%
+10%
-6%
+3%
+21%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$9.2M
$12.1M
$9.8M
$9.7M
$10.1M
$11.4M
$10.1M
$11.7M
Margins · last 8Q
Gross
72.1%
Operating
-19.3%
Profit
-34.4%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Ascendiant Capital · Aug 27, 2026
vs Industry
How MYO stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.